Nrc Health (NRC) Insider Trading

Last 12 months

Insiders bought $98k on the open market and sold nothing.

Net open-market

+$98k

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Feb 2026

Feb 17, 2026

Get an email when NRC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 17	Shane R Harrison EVP & Chief Financial Officer	Bought	8,000	$12.27	$98k	5.3%	Form 4
Jul 31, 2025	Jordan Nicole Freeman Chief Accounting Officer	Bought	771	$12.97	$10k	New	Form 4
May 12, 2025	Patrick E Beans Large holder	Bought	2,500	$13.59	$34k	7.7%	Form 4

Feb 17
Shane R Harrison
EVP & Chief Financial Officer · bought 8,000 at $12.27
$98k
5.3% of stake
Jul 31, 2025
Jordan Nicole Freeman
Chief Accounting Officer · bought 771 at $12.97
$10k
New position
May 12, 2025
Patrick E Beans
Large holder · bought 2,500 at $13.59
$34k
7.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NRC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Commercial Physical & Biological Research

OABIOmniAb, Inc.

MXCTMaxCyte, Inc.

FOXOFoxo Technologies Inc.

NOTVInotiv Inc.

NEONeoGenomics Inc.

MHHMastech Digital Inc.

ITXPIndependence Power Holdings, Inc.

PPHCPublic Policy Holding Company, Inc.

Spot a number that looks wrong? Check it in NRC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NRC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.